Mounjaro 5 mg (Tirzepatide) is an advanced injectable peptide featuring a dual-action mechanism targeting both GIP and GLP-1 receptors. This combination supports comprehensive metabolic regulation, including blood sugar balance and body weight management.

Manufacturer: Eli Lilly
Form: Pre-filled KwikPen injection
Dosing frequency: Once weekly

Each package contains 4 doses of 5 mg. Designed for once-weekly use.

How Mounjaro Works

Tirzepatide activates two key hormonal pathways:

• GIP: enhances insulin secretion and improves insulin sensitivity;
• GLP-1: reduces appetite, slows gastric emptying, and regulates glucagon levels.

This dual mechanism helps maintain stable blood sugar levels, reduce hunger, and support overall energy balance.

Key Benefits of Mounjaro 5 mg

• Supports healthy blood sugar levels;
• Promotes weight loss and appetite control;
• Helps reduce visceral fat;
• Supports cholesterol balance;
• May contribute to improved cardiovascular markers.

Indications for Use

• Type 2 diabetes support;
• Insulin resistance;
• Overweight and obesity;
• Metabolic imbalance.

Dosage & Administration

It is recommended to start with 2.5 mg for the first 4 weeks, then gradually increase the dose based on individual response.

Administration:

• Subcutaneous injection;
• Abdomen;
• Thigh;
• Upper arm.

Rotate injection sites to improve tolerability.

Possible Side Effects

• Nausea;
• Digestive discomfort;
• Reduced appetite.

Rare:

• Pancreatitis;
• Gallbladder issues;
• Allergic reactions.

Storage

• Temperature: 2–8°C (36–46°F);
• Do not freeze;
• Protect from direct light.

Summary

Mounjaro 5 mg (Tirzepatide) is a modern solution for metabolic optimization and weight management. Its dual-action mechanism and convenient KwikPen format make it suitable for long-term use under professional supervision.

Related Products

Check higher dosage option: Mounjaro 15 mg KwikPen